Cargando…
The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
Oral squamous cell carcinoma (OSCC) is a kind of malignant tumors with low survival rate and prone to have early metastasis and recurrence. Cisplatin is an alkylating agent which induces DNA damage through the formation of cisplatin-DNA adducts, leading to cell cycle arrest and apoptosis. In the man...
Autores principales: | Cheng, Yali, Li, Shaoming, Gao, Ling, Zhi, Keqian, Ren, Wenhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569522/ https://www.ncbi.nlm.nih.gov/pubmed/34746001 http://dx.doi.org/10.3389/fonc.2021.761379 |
Ejemplares similares
-
Diagnostic Value of CircRNAs as Potential Biomarkers in Oral Squamous Cell Carcinoma: a Meta-Analysis
por: Wang, Mingfei, et al.
Publicado: (2021) -
Circ-PKD2 promotes Atg13-mediated autophagy by inhibiting miR-646 to increase the sensitivity of cisplatin in oral squamous cell carcinomas
por: Gao, Ling, et al.
Publicado: (2022) -
The microRNA-10b-Bim axis promotes cancer progression through activating autophagy in oral squamous cell carcinoma
por: Li, Shaoming, et al.
Publicado: (2022) -
The RBP1–CKAP4 axis activates oncogenic autophagy and promotes cancer progression in oral squamous cell carcinoma
por: Gao, Ling, et al.
Publicado: (2020) -
In Vitro Study of Synergic Effect of Cisplatin and Low Molecular Weight Heparin on Oral Squamous Cell Carcinoma
por: Camacho-Alonso, Fabio, et al.
Publicado: (2020)